MedPath

Efficacy of intravenous muscle relaxants for supplying regional muscle relaxation in order to improve relaxation of leg muscles in patients undergoing knee arthroscopy.

Phase 4
Conditions
knee arthroscopy
Anaesthesiology - Other anaesthesiology
Surgery - Other surgery
Registration Number
ACTRN12616001357448
Lead Sponsor
Dr MD Irfan Gungor
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
22
Inclusion Criteria

Patients (aged of 18-65 yr) with American Society of Anesthesiologists (ASA) physical status I-III, scheduled for elective knee arthroscopy under combined sciatic and femoral paravascular nerve blocks were included in the study.

Exclusion Criteria

Refusal to participate, ASAphysical status IV-V, patients with serious hepatic, renal or cardiovascular disease, neurologic/neuromuscular disease, epilepsy,
peripheral neuropathy, chronic analgesic consumption, unable to cooperate with this research due to cognitive impairment (neuro-psychiatric disease), under medication with anticoagulants, allergy to local anesthetics, pregnancy or breastfeeding, infection at the site of injection and patients with metallic implants (cardiac pacemaker, aneurysm clip etc..)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath